Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$2.04B |
| 2 |
Microsoft
MSFT
|
+$941M |
| 3 |
Alibaba
BABA
|
+$782M |
| 4 |
McDonald's
MCD
|
+$625M |
| 5 |
Home Depot
HD
|
+$409M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.96B |
| 2 |
Chipotle Mexican Grill
CMG
|
+$765M |
| 3 |
Dollar General
DG
|
+$609M |
| 4 |
Apple
AAPL
|
+$489M |
| 5 |
AGN
Allergan plc
AGN
|
+$419M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.98% |
| 2 | Consumer Discretionary | 18.73% |
| 3 | Communication Services | 15.16% |
| 4 | Technology | 12.68% |
| 5 | Financials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRX
476
DELISTED
Chimerix, Inc.
CMRX
| $11.4M | 0.01% |
1,273,779
+515,029
| +68% | +$18.5M |
|
|
TVRD
477
Tvardi Therapeutics
TVRD
$19.7M
| $11.1M | 0.01% |
18,235
+56
| +0.3% | +$30.7K |
|
|
DTEA
478
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
| $10.9M | 0.01% |
880,679
+13,712
| +2% | +$187K |
|
479
Freeport-McMoran
FCX
$90B
| $10.9M | 0.01% |
1,610,929
-201,697
| -11% | -$1.92M |
|
|
GNMX
480
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $10.5M | 0.01% |
1,748,112
+906,153
| +108% | +$6.15M |
|
481
Prestige Consumer Healthcare
PBH
$2.38B
| $10.3M | 0.01% |
+199,233
| New | +$9.9M |
|
482
CALL
Bausch Health
BHC
$2.58B
| $10.2M | 0.01% |
+100,000
| New | +$11.2M |
|
|
GBT
483
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $10.1M | 0.01% |
312,822
-56,709
| -15% | -$2.46M |
|
|
MNDT
484
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $9.7M | 0.01% |
467,524
-8,474,654
| -95% | -$212M |
|
|
HAPN
485
Happen Inc
HAPN
$2.21B
| $9M | 0.01% |
162,874
+6,008
| +4% | +$398K |
|
486
ProQR Therapeutics
PRQR
$243M
| $8.7M | 0.01% |
1,001,774
+33,019
| +3% | +$380K |
|
487
Coherus Oncology
CHRS
$217M
| $8.43M | 0.01% |
367,021
+11,023
| +3% | +$284K |
|
488
Qualys
QLYS
$5.1B
| $8.4M | 0.01% |
253,730
+3,467
| +1% | +$122K |
|
489
Standard BioTools
LAB
$340M
| $8.29M | 0.01% |
767,144
-320,506
| -29% | -$3.15M |
|
490
MacroGenics
MGNX
$235M
| $8.28M | 0.01% |
267,408
+909
| +0.3% | +$27.6K |
|
491
Chord Energy
CHRD
$7.9B
| $8.28M | 0.01% |
1,122,924
-131,134
| -10% | -$1.4M |
|
|
DMTX
492
DELISTED
Dimension Therapeutics, Inc
DMTX
| $8.27M | 0.01% |
+742,454
| New | +$9.4M |
|
493
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $8.26M | 0.01% |
+40,494
| New | +$8.32M |
|
|
DCOY
494
Decoy Therapeutics
DCOY
$2.19M
| $8.18M | 0.01% |
1
| – | – |
|
|
EPRS
495
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $8.03M | 0.01% |
2,597,868
+3,912
| +0.2% | +$17.6K |
|
496
Semtech
SMTC
$11B
| $7.93M | 0.01% |
418,966
-1,238,374
| -75% | -$22.6M |
|
|
DYN.PRA
497
DELISTED
Dynegy Inc.
DYN.PRA
| $7.61M | 0.01% |
150,165
-95,586
| -39% | -$6.18M |
|
498
Brookfield Infrastructure Partners
BIP
$19.2B
| $7.41M | 0.01% |
492,342
+205,737
| +72% | +$3.28M |
|
|
TRVN
499
DELISTED
Trevena, Inc.
TRVN
| $7.38M | 0.01% |
1,124
+4
| +0.4% | +$26.8K |
|
500
Enterprise Products Partners
EPD
$82.3B
| $7.01M | 0.01% |
274,170
+194,913
| +246% | +$5.06M |
|
Similar funds
Jennison Associates's Q4 2015 Portfolio in Review
As of Q4 2015, Jennison Associates held 786 positions worth $102B, up 4.4% from $97.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jennison Associates's Q4 2015 filing shows 65 new, 298 increased, 279 reduced and 131 closed positions. Its largest new stake was Alphabet (Google) Class A: 55,026,880 shares worth $2.14B. The largest sale was Alphabet (Google) Class C, an estimated $1.96B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2015 buy was Alphabet (Google) Class A: 55,026,880 shares worth $2.14B.
- Jennison Associates added most to Microsoft in Q4 2015, an estimated $941M increase.
- Jennison Associates's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $1.96B.
- Jennison Associates fully exited Chipotle Mexican Grill in Q4 2015, selling an estimated $765M.
- Jennison Associates's ten largest holdings make up 23% of its $102B portfolio in Q4 2015.
- Jennison Associates opened 65 new positions and closed 131 in Q4 2015.
- Jennison Associates's portfolio value rose 4.4% quarter-over-quarter to $102B.
Based on Jennison Associates's 13F filing for Q4 2015, filed 10 Feb 2016.